On Tuesday, 21st March 2023, Arthritis Australia and the Juvenile Arthritis Foundation Australia (JAFA) issued a media release warning of a looming crisis in arthritis that could hit the community and the economy hard.
A new report from the ABS using the 2021 Census dataset finds that approximately 8 million Australians live with a long-term health condition. Over 2.1 million Australians live with arthritis.
The shortages of abatacept (Orencia®) subcutaneous products in Australia will be resolved from 1 July 2022.
Stay up-to-date with information on COVID-19 for people living with arthritis.
Your gift will help fund self-management courses, education seminars and will provide individual support for people living with arthritis.